GPhA’s Neas Preaches Vigilance Against Reopening Hatch-Waxman Act
By
Sue Sutter / Email the Author / “The Pink Sheet” Feb. 20, 2012, Vol. 74, No. 8
Generic Drugs / Word Count: 2203 / Article # 00120220010
Executive Summary
After five months on the job, Generic Pharmaceutical Association President and CEO Ralph Neas is optimistic about the industry’s future but prepared to do battle against any efforts to re-work the landmark 1984 law. Preparations include establishing a new non-profit arm, the Affordable Medicine Research Institute, which will focus on research and public education about generics and biosimilars.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.